Early prediction of response to therapy: the clinical implications in Hodgkin’s and non-Hodgkin’s lymphoma Lale Kostakoglu Editorial 02 April 2008 Pages: 1413 - 1420
Optimizing interventions for preventing uptake in the brown adipose tissue in FDG-PET Sandip BasuAbass Alavi Editorial 19 March 2008 Pages: 1421 - 1423
FDG avidity and PET/CT patterns in primary gastric lymphoma Lea RadanDoron FischerOra Israel Original Article 17 April 2008 Pages: 1424 - 1430
Comparison between 68Ga-DOTA-NOC and 18F-DOPA PET for the detection of gastro-entero-pancreatic and lung neuro-endocrine tumours Valentina AmbrosiniPaola TomassettiStefano Fanti Original Article 17 April 2008 Pages: 1431 - 1438
Performance of integrated FDG–PET/contrast-enhanced CT in the diagnosis of recurrent ovarian cancer: comparison with integrated FDG–PET/non-contrast-enhanced CT and enhanced CT Kazuhiro KitajimaKoji MurakamiKazuro Sugimura Original Article 17 April 2008 Pages: 1439 - 1448
Influence of the thyroid remnant in the elevation of the serum thyroglobulin after thyroidectomy in differentiated thyroid carcinoma. Importance of the diagnostic iodine total-body scanning Elisa Caballero-CalabuigCarmen Cano-TerolJesús Félix-Fontestad Original article 17 April 2008 Pages: 1449 - 1456
Length and cost of hospital stay of radioiodine ablation in thyroid cancer patients: comparison between preparation with thyroid hormone withdrawal and thyrogen I. BorgetH. RemyG. De Pouvourville Original article 02 April 2008 Pages: 1457 - 1463
Quality of planar whole-body bone scan interpretations—a nationwide survey May SadikMadis SuurkulaLars Edenbrandt Original Article 29 March 2008 Pages: 1464 - 1472
[18F]Fluorinated estradiol derivatives for oestrogen receptor imaging: impact of substituents, formulation and specific activity on the biodistribution in breast tumour-bearing mice François BénardNaseem AhmedJohan E. van Lier Original Article 13 March 2008 Pages: 1473 - 1479
Tracking cellular stress with labeled FMAU reflects changes in mitochondrial TK2 Omid S. TehraniKirk A. DouglasAnthony F. Shields Original Article 12 February 2008 Pages: 1480 - 1488
Evaluation of biodistribution and anti-tumor effect of a dimeric RGD peptide–paclitaxel conjugate in mice with breast cancer Qizhen CaoZi-Bo LiXiaoyuan Chen Original Article 29 March 2008 Pages: 1489 - 1498
Biodistribution and radiation dosimetry of the A1 adenosine receptor ligand 18F-CPFPX determined from human whole-body PET Hans HerzogDavid ElmenhorstAndreas Bauer Original article 29 March 2008 Pages: 1499 - 1506
68Ga- and 111In-labelled DOTA-RGD peptides for imaging of αvβ3 integrin expression Clemens DecristoforoIgnacio Hernandez GonzalezRoland Haubner Original article 28 March 2008 Pages: 1507 - 1515
Effects of AV delay programming on ventricular resynchronisation: role of radionuclide ventriculography Patrick T. SiegristNathalie ComtePhilipp A. Kaufmann Original article 19 March 2008 Pages: 1516 - 1522
Evaluation of a decision support system for interpretation of myocardial perfusion gated SPECT Milan LomskyPeter GjertssonLars Edenbrandt Original Article 04 March 2008 Pages: 1523 - 1529
99mTc sestamibi myocardial perfusion scintigraphy with the novel use of metamizol for the detection of perfusion reversibility Eser Lay ErgünMeltem CaglarHakan Ergün Original Article 29 February 2008 Pages: 1530 - 1536
18F-FDG PET/CT in sarcoidosis management: review and report of 20 cases Jean Jacques BraunRomain KesslerAlessio Imperiale Original Article 17 April 2008 Pages: 1537 - 1543
FDG uptake, a surrogate of tumour hypoxia? Rudi Andre DierckxChristophe Van de Wiele Review article Open access 29 May 2008 Pages: 1544 - 1549
PET–MRI synergy in molecular, functional and anatomical cancer imaging Giovanni Lucignani Focus on 15 May 2008 Pages: 1550 - 1553
Planar and SPECT imaging in the era of PET and PET–CT: can it survive the test of time? Abass AlaviSandip Basu Controversies 02 July 2008 Pages: 1554 - 1559
Is PET always an advantage versus planar and SPECT imaging? Giuliano MarianiLaura BruselliAdriano Duatti Controversies 09 May 2008 Pages: 1560 - 1565
C. Richard Goldfard, Steven R. Parmett, Lionel S. Zuckier, Fukiat Ongseng, Maroun Karam, Jeffrey A. Cooper (eds), Nuclear Medicine Board Review: questions and answers for self assessment. (Second Edition) M. P. M. StokkelLuigi Mansi Book review Open access 12 April 2008 Pages: 1566 - 1566
Prostate biopsy guided by 18F-fluorocholine PET in men with persistently elevated PSA levels Sandi A. KweeTim DeGrado Letter to the editor 03 June 2008 Pages: 1567 - 1569
Prostate biopsy guided by 18F-fluorocholine PET in men with persistently elevated PSA levels I. IgercP. Lind Letter to the editor 03 June 2008 Pages: 1570 - 1570
99mTc-Tetrofosmin SPECT for the detection of glioma recurrence George A. AlexiouSpyridon TsiourisAndreas D. Fotopoulos Letter to the Editor 20 May 2008 Pages: 1571 - 1572
Improving outcome after positive interim PET in advanced Hodgkin’s disease: reality vs expectation Panayiotis D. ZiakasLoukia S. Poulou Letter to the Editor 29 May 2008 Pages: 1573 - 1575
PET-CT—comments on the white paper H.-J. Biersack Letter to the Editor 20 June 2008 Pages: 1576 - 1576
Whole body 18fluoro-l-dopa PET–CT: a useful tool for location and surgical guidance in primary carcinoid tumours J. ArbizuM. Rodriguez-FraileJ. A. Richter Image of the Month 20 June 2008 Pages: 1577 - 1577
Annual congress of the EANM 2007, Copenhagen, Denmark Abstracts Tuesday H. DemirY. Z. TanF. Berk Erratum 20 June 2008 Pages: 1578 - 1578
TENTH ANNIVERSARY OF THE DEPARTMENT OF NUCLEAR MEDICINE OF THE CLINIQUE STE THÉRÈSE IN LUXEMBOURG Society Communications 08 July 2008 Pages: 1579 - 1580
Guidelines for 18F-FDG PET and PET-CT imaging in paediatric oncology J. StaussC. FranziusK. Hahn Guidelines 07 June 2008 Pages: 1581 - 1588